Back to results
US 11,691,944 B2Granted
Solabegron zwitterion and uses thereof
AssigneeB3Ar Therapeutics, Inc.
InventorsRaymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
Life of this patent
Estimating the term…
Abstract
This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
Claims19
A solid compound according to Formula II:
- or a pharmaceutically acceptable salt, or stereoisomer, thereof, wherein the solid compound is an anhydrous crystalline solid or hydrated isopropanol solvate.
A pharmaceutical composition comprising:
- a therapeutically effective amount of a solid compound according to Formula II:
- or a pharmaceutically acceptable salt, or stereoisomer, thereof, wherein the solid compound is an anhydrous crystalline solid or hydrated isopropanol solvate;
- and
- at least one pharmaceutically acceptable carrier or excipient.
1 more element
Dependencies are inferred from the claim text.